Elastrin has the attributes that investors in early stage startups are looking for.
Successful Seed Investment Round led by Kizoo Technological Capital
Elastrin is proud to be supported by an established VC that is comprised of like-minded people who share our vision. KIZOO provides mentoring, seed and early-stage financing with a focus on rejuvenation biotech.
Reliable R&D track record.
See our heritage.
Diverse experienced team.
See our team page. Founders, advisors and professional consultants are part of the mix.
Powerful growth potential.
See therapy development. The technology has the potential to be licensed out across a variety of disease conditions. It meets an unmet need for millions of patients but also has orphan designation potential for rapid approvals.
Early asset development.
A powerful and unique antibody.
Defensible IP and strong unique selling point.